International Archives of Allergy and Immunology
Original Paper
BCG Priming of Dendritic Cells Enhances T Regulatory and Th1 Function and Suppresses Allergen-Induced Th2 Function in vitro and in vivoAhrens B.a · Grüber C.a · Rha R.-D.a · Freund T.a · Quarcoo D.a, b · Awagyan A.a · Hutloff A.c · Dittrich A.M.a, d · Wahn U.a · Hamelmann E.a, eaDepartment of Paediatric Pneumology and Immunology, and bInstitute of Occupational Medicine, Charité Universitätsmedizin Berlin, and cMolecular Immunology, Robert Koch Institute, Berlin, dNachwuchsgruppe SFB 587, Hannover Medical University, Hannover, and eUniversity Children Hospital, Ruhr University, Bochum, Germany
Keywords: CytokineAllergyInflammationLung |
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: June 06, 2008
Accepted: January 14, 2009
Published online: June 03, 2009
Issue release date: October 2009
Number of Print Pages: 11
Number of Figures: 9
Number of Tables: 0
ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)
For additional information: https://www.karger.com/IAA
Abstract
Background: The inverse correlation of mycobacterial infection with asthma prevalence and the inhibitory effects of vaccination with Bacille Calmette-Guérin (BCG) on airway hyperreactivity in asthma models suggest modulation of dendritic cell (DC) and T cell functions by mycobacterial compounds. Methods: To delineate these immunological effects, the immunogenicity of BCG Copenhagen, BCG Chicago and BCG Pasteur was compared in a mouse model. Bone marrow-derived dendritic cells (BMDCs) from BALB/c mice were stimulated with ovalbumin (OVA) with or without BCG. BMDCs were phenotypically characterized by flow cytometry, and we used ELISA to measure the cytokine production of BMDCs as well as of co-cultivated allergen-specific T cells in response to OVA-pulsed. Immunomodulatory effects of BCG were studied in a model of allergic airway inflammation by adoptive transfer of allergen-pulsed BMDCs. Results: Immunomodulation with BCG induced production of IL-10 and IL-12 by BMDCs. Co-cultured allergen-specific T cells produced less IL-5, IL-13 and IFN-γ but more IL-10. Also the number of FoxP3+ regulatory T cells was enhanced. Strongest effects were seen with BCG Chicago and BCG Pasteur. In vivo, administration of BCG modulated OVA-pulsed BMDCs then reduced eosinophilic airway inflammation but enhanced infiltration with granulocytes. Airway hyperreactivity and mucus production were reduced and more FoxP3+ T cells were observed. Conclusion: BCG-induced suppression of Th2-type allergic airway inflammation was associated with enhancement of regulatory T cell function but also of Th1-associated neutrophilic airway inflammation. These findings raise concerns regarding the safety profile of BCG as a potential tool for prevention and therapy of allergic airway disease.
© 2009 S. Karger AG, Basel
Related Articles:
References
- Rook GAW, Hamelmann E, Brunet LR: Mycobacteria and allergies. Immunobiology 2007;212:461–473.
- Matricardi PM, Yazdanbakhsh M: Mycobacteria and atopy, 6 years later: a fascinationg, still unfinished, business. Clin Exp Allergy 2003;33:717–720.
-
Shirakawa T, Enomoto T, Sihimazu S, Hopkin JM: The inverse association between tuberculin responses and atopic disorder. Science 1996;275:77–79.
External Resources
- von Hertzen L, Klaukka T, Mattila H, Haahtela H: Mycobacterium tuberculosis infection and the subsequent development of asthma and allergic conditions. J Allergy Clin Immunol 1999;104:1211–1214.
- von Mutius E, Pearce N, Beasley R, Cheng S, von Ehrenstein O, Björkstén B, Weiland S: International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis and eczema. Thorax 2000;55:449–453.
- Erb KJ, Holloway JW, Solbeck A, Moll H, LeGros G: Infection of mice with Myco bacterium bovis-Bacillus Calmette-Guérin (BCG) suppresses allergen-induced airway eosinophiilia. J Exp Med 1998;187:561–569.
- Herz U, Gerhold K, Grüber C, Braun A, Wahn U, Renz H, Paul K: BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J Allergy Clin Immunol 1998;102:867–874.
- Strachan DP: Family size, infection and atopy: the first decade of the ‘hygiene hypothesis’. Thorax 2000;55(suppl 1):S2–S10.
-
Martinez FD, Holt PG: Role of microbial burden in aetiology of allergy and asthma. Lancet 1999;354(suppl 2):SII12–SII15.
- Palucka K, Banchereau J: Dendritic cells: a link between innate and adaptive immunity. J Clin Immunol 1999;19:12–25.
- Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Bolcskei PL, Wagner M, Akira S, Norgard MV, Belisle JT, Godowski PJ, Bloom PR, Moodlin RL: Induction of direct antimicrobial activity through mammalian toll-like receptors. Science2001;291:1544–1547.
- Abel B, Thieblemont N, Quesniaux VJF, Brown N, Mpagi J, Miyake K, Bihl F, Ryffel B: Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002;169:3155–3162.
- Fricke I, Mitchell D, Mittelstadt J, Lehan N, Heine H, Goldmann T, Bohle A, Brandau S: Mycobacteria induce IFN-γ production in human dendritic cells via triggering of TLR2. J Immunol 2006;176:5173–5182.
- Langenkamp A, Messi M, Lanzavecchia A, Sallusto F: Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat Immunol 2000;1:311–316.
- Boonstra A, Asselin-Paturel C, Gilliet M, Crain C, Trinchieri G, Liu YJ, O’Garra A: Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003;197:101–109.
- Grüber C, Kulig M, Bergmann RL, Guggenmoos-Holzmann I, Wahn U, and the MAS-90 Study Group: Delayed hypersensitivity to tuberculin, total immunoglobulin E, specific sensitization and atopic manifestation in longitudinally followed early Bacille Calmette-Guérin-vaccinated and nonvaccinated children. Pediatrics 2001;107:E36.
- Vargas MH, Bernal-Alcantara DA, Vaca MA, Franco-Marina F, Lascurain R: Effect of BCG vaccinaion in asthmatic schoolchildren. Pediatr Allergy Immunol 2004;15:415–420.
- MA Behr: BCG: different strains, different vaccines? Lancet Infect Dis 2002;2:86–92.
- Smith D, Harding G, Chan J, Edwards M, Hank J, Muller D, Sobhi F: Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs. J Biol Stand 1979;7:179–197.
- Lagranderie M, Balazuc AM, Deriaud E, Leclerc CD, Gheorghiu M: Comparison of immune responses of mice immunised with five different Mycobacterium bovis BCG vaccine strains. Infect Immun 1996;64:1–9.
- Choi IS, Lin XH, Koh YA, Koh YI, Lee HC: Strain-dependent suppressive effects of BCG vaccination on asthmatic reactions in BALB/c mice. Ann Allergy Asthma Immunol 2005;95:571–578.
- Lutz MB, Kukutsch N, Ogilvie ALJ, Rossner S, Koch F, Romani N, Schuler F: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999;223:77–92.
- Lyons AB, Parish CR: Determination of lymphocyte division by flow cytometry. J Immunol Methods 1994;171:131–137.
- Ahrens B, Witzenrath M, Kube S, Hocke AC, Rosseau S, Suttorp N, Hamelmann E, Schütte H: Detection of allergen-induced airway hyperresponsivness in isolated mouse lungs. Am J Physiol Lung Cell Mol Physiol 2006;291:L466–L472.
- Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med 1997;156:766–775.
- Dubos RJ, Pierce CG: Differential characteristics in vitro and in vivo of several substrains of BCG. 1. Multiplication and survival in vitro. Am Rev Tuberc Pulm Dis 1956;74:655–666.
- Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY: Regulatory T cell lineage specification by the forkhead transcription factor FoxP3. Immunity 2005;22:329–341.
- Hanekom WA: The immune response to BCG vaccination of newborns. Ann NY Acad Sci 2005;1062:69–78.
- Hamelmann E, Gelfand EW: IL-5-induced airway eosinophilia: the key to asthma? Immunol Rev 2001;179:182–191.
- Dabbagh K, Takeyama K, Lee HM, Ueki IF, Lausier JA, Nadel JA: IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162:6233–6237.
- Quarcoo D, Weixler S, Joachim RA, Stock P, Kallinich T, Ahrens B, Hamelmann E: Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. Clin Exp Allergy 2004;34:1314–1320.
- Gavett SH, O’Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527–1236.
- Lack G, Bradley KL, Hamelmann E, Renz H, Loader J, Leung DY, Larsen G, Gelfand EW: Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. J Immunol 1996;157:1432–1439.
- Hansen G, Berry G, DeKruyff RH, Umetsu DT: Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999;103:175–183.
- Randolph DA, Carruthers CJ, Szabo SJ, Murphy KM, Chaplin DD: Modulation of airway inflammation by passive transfer of allergen-specific Th1 and Th2 cells in a mouse model of asthma. J Immunol 1999;162:2375–2383.
Article / Publication Details
Received: June 06, 2008
Accepted: January 14, 2009
Published online: June 03, 2009
Issue release date: October 2009
Number of Print Pages: 11
Number of Figures: 9
Number of Tables: 0
ISSN: 1018-2438 (Print)
eISSN: 1423-0097 (Online)
For additional information: https://www.karger.com/IAA
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
